Empowered Funds, LLC

SEC CIK: 0001592828
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

KROS holding history

Keros Therapeutics, Inc. in every 13F filed by Empowered Funds, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KROS overview All 13F holders of KROS Full Q2 2026 holdings

Shares (Q2 2026): 142,151
Value: $1.52M
% of portfolio: <0.1%
Quarters held: 2; Since Q1 2026

Holdings of KROS by Empowered Funds, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	142,151	$1.52M	<0.1%	−3,366−2.3%	Reduced	Holders
Q1 2026	145,517	$1.61M	<0.1%	+145,517	New	Holders